Compounded tirzepatide is not the same as FDA-approved Zepbound, and companies should not market it as a generic Zepbound
For better medication application on anti-obesity, we suggest in the future, large sample size, more varieties of ethnic, multi-center collaboration with high-quality randomized controlled trials to be conducted
As such, GLP-1 has been studied as a potential therapeutic for the treatment and management of high-impact neurodegenerative disorders, namely Alzheimers disease (AD) and Parkinsons disease (PD)
Individual responses still vary
Evaluation of polylactic acid homopolymers as carriers for bone morphogenetic protein
To explore potential associations between urolithin metabotype and TMAO response variability, plasma TMAO AUC was stratified by metabotype